Molecular Pathology of Myotonic Dystrophy Type 1 in Iceland. [PDF]
Hallgrímsdóttir EG +7 more
europepmc +1 more source
High Resolution Analysis of DMPK Hypermethylation and Repeat Interruptions in Myotonic Dystrophy Type 1. [PDF]
Rasmussen A +5 more
europepmc +1 more source
Cardiac Involvement in Myotonic Dystrophy Type 1: Mechanisms, Clinical Perspectives, and Emerging Therapeutic Strategies. [PDF]
Ginjupalli VKM +4 more
europepmc +1 more source
MRCK-Alpha and Its Effector Myosin II Regulatory Light Chain Bind ABCB4 and Regulate Its Membrane Expression. [PDF]
Bruneau A +11 more
europepmc +1 more source
Fifteen Years of Myotonic Dystrophy Type 1 in Mexico: Clinical, Molecular, and Socioeconomic Insights from a National Reference Cohort. [PDF]
Cerecedo-Zapata CM +12 more
europepmc +1 more source
Prostate Cancer Secretome and Membrane Proteome from Pten Conditional Knockout Mice Identify Potential Biomarkers for Disease Progression. [PDF]
Santos NJ +4 more
europepmc +1 more source
Comparative Analysis of the Structure and Pharmacological Properties of Some Piperidines and Host-Guest Complexes of β-Cyclodextrin. [PDF]
Kemelbekov U +5 more
europepmc +1 more source
Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts. [PDF]
Viegas D +6 more
europepmc +1 more source
MBNL overexpression rescues cardiac phenotypes in a myotonic dystrophy type 1 heart mouse model. [PDF]
Hu RC +7 more
europepmc +1 more source
Small Molecule Screening Identifies HSP90 as a Modifier of RNA Foci in Myotonic Dystrophy Type 1. [PDF]
Johnson SJ +5 more
europepmc +1 more source

